-transparent.png){kind=logo}
In diabetic patients plasma levels of pancreatic polypeptide (PP) increased four fold after intramuscular injection of secretin (50 CHRU, Eisai Co.) in spite of the lack of response of plasma insulin, plasma glucagon and blood glucose levels. In control subjects, PP levels did not change significantly after secretin injection. Since pancreatic polypeptide has is known to have an inhibitory effect on the exocrine pancreas, the present study suggests the possibility that disturbed function of the exocrine pancreas in diabetic patients could be related to the remarkable response of PP to secretin-stimulation.
Related Publications
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
October 1978,
Life sciences,
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
November 1985,
Regulatory peptides,
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
July 1999,
European journal of endocrinology,
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
November 1979,
Zeitschrift fur Gastroenterologie,
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
January 1979,
Gut,
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
July 1978,
Schweizerische medizinische Wochenschrift,
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
May 1981,
The Journal of physiology,
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
April 1989,
FEBS letters,
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
October 1986,
Annals of internal medicine,
T Toyota, and
M Koizumi, and
Y Kai, and
M Miura, and
M Umetsu, and
S Suzuki, and
Y Goto
February 2003,
The Journal of clinical endocrinology and metabolism,
